CA
NZ
UK
AU
IND
US
Bitmine Immersion Technologies, Inc. has disclosed recent stock transactions involving its director, Robert J. Sechan II. The transactions, which occurred on July 23, 2026, included the acquisition of restricted stock units (RSUs) and common stock. This development is noteworthy for investors as it reflects …
Bitmine Immersion Technologies, Inc. has disclosed a recent transaction involving its director, Jason A. Edgeworth. The announcement details the acquisition of restricted stock units (RSUs) that have now vested, which may influence investor sentiment regarding the company's governance and insider ownership structure.
Bitmine Immersion Technologies, Inc. has disclosed a transaction involving the acquisition of restricted stock units (RSUs) by Michael Stephen Maloney, a director of the company. This acquisition is significant as it reflects the ongoing commitment of the company's leadership to its growth and aligns …
Bitmine Immersion Technologies, Inc. has disclosed a recent transaction involving the acquisition of common stock by Olivia Howe, a director of the company. This development, resulting from the vesting of restricted stock units (RSUs), highlights the company's ongoing commitment to align executive interests with …
Bitmine Immersion Technologies has disclosed a significant insider transaction involving the acquisition of common stock by director Lori Love. This acquisition, which took place on July 23, 2026, is part of the vesting of restricted stock units granted earlier this year. Such transactions may …
CorVel Corporation has disclosed a significant transaction involving its CEO, Sarah Scott, who acquired 25,000 shares through a non-qualified stock option. This acquisition, reported on July 24, 2026, may draw attention from investors as it reflects the leadership's confidence in the company's future. The …
NEKTAR THERAPEUTICS has disclosed the vesting of stock options for its President and CEO, Robin Howard W. This development is significant as it reflects the company's ongoing performance-based compensation strategy. Investors may find this information relevant as it pertains to executive incentives and potential …
Nektar Therapeutics has announced the vesting of stock options held by Chief R&D Officer Jonathan Zalevsky, a development that may interest investors tracking executive compensation and performance incentives. The stock options were granted under the company's 2017 Amended and Restated Performance Incentive Plan, reflecting …
Heartflow, Inc. has disclosed a recent transaction involving its Director Timothy Barabe, who reported changes in his beneficial ownership of the company's stock. This update is significant for investors as it reflects insider activity that can influence perceptions of the company's performance and future …
First Interstate Bancsystem Inc. has reported a significant acquisition of shares by its director, Brian Kevin Turner. The transaction took place on July 22, 2026, and highlights ongoing investment by key management, which may be of interest to investors monitoring insider activities.
Please wait processing your request...